Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.0K
Cancer02:18

Cancer

52.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
52.7K
Tumor Progression02:07

Tumor Progression

7.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.5K
Cancer Survival Analysis01:21

Cancer Survival Analysis

551
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
551
What is Cancer?02:12

What is Cancer?

13.1K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
13.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptional heterogeneity predicts and enables clonal selection in ageing haematopoiesis.

Research square·2026
Same author

When effective anticancer therapies are, in fact, destabilizing the tumor's Group Phenotypic Composition.

NPJ precision oncology·2026
Same author

Cytokine preactivation and ADCC: a potent strategy for enhancing human NK cell effector functions against 3D tumor models.

Frontiers in immunology·2026
Same author

Cathepsin B protease mediates high population density-induced mutagenesis to drive genome evolution and competitive growth.

Nature communications·2026
Same author

Selection for Function in Early Life: Implications for Early-Onset Pathologies.

Evolutionary applications·2026
Same author

Hematopoietic stem cell aging promotes <i>TET2</i> clonal hematopoiesis.

Research square·2026
Same journal

Advancing microalgae biomass cultivation for an integrated sustainable wastewater treatment and resource recovery.

iScience·2026
Same journal

Corrigendum to "Human adipose ECM alleviates radiation-induced skin fibrosis via endothelial cell-mediated M2 macrophage polarization" [iScience, Volume 26, Issue 9 (2023) 107660].

iScience·2026
Same journal

High-definition transcranial direct current stimulation enhances exercise-induced hypoalgesia in patients with chronic low back pain.

iScience·2026
Same journal

From pre-tumor to tumor: Decoding the endoscopic-pathologic spectrum of neoplastic lesions in autoimmune gastritis.

iScience·2026
Same journal

Corrigendum to "A cobalt-aluminium layered double hydroxide with a nickel core-shell structure nanocomposite for supercapacitor applications" [iScience, 28 (2025) 111672].

iScience·2026
Same journal

Repurposing primaquine diphosphate for imatinib-resistant chronic myeloid leukemia via targeting BCR-ABL and Wnt/β-catenin pathway.

iScience·2026
See all related articles

Related Experiment Video

Updated: Dec 2, 2025

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.6K

Approaching Cancer Evolution from Different Angles.

Francesca D Ciccarelli1,2, James DeGregori3

  • 1Cancer Systems Biology Laboratory, the Francis Crick Institute, London, NW1 1AT, UK.

Iscience
|November 2, 2020
PubMed
Summary
This summary is machine-generated.

This discussion highlights advancements and challenges in clinical, molecular, and evolutionary cancer research. Experts share insights on the current state of knowledge and future opportunities in cancer studies.

More Related Videos

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

649
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.0K

Related Experiment Videos

Last Updated: Dec 2, 2025

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.6K
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

649
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.0K

Area of Science:

  • Integrative cancer research spanning clinical, molecular, and evolutionary domains.
  • Multidisciplinary perspectives on cancer biology and treatment strategies.

Background:

  • Interviews with leading scientists in clinical, molecular, and evolutionary cancer research.
  • Focus on the current landscape of cancer knowledge and ongoing investigations.

Discussion:

  • Exploration of key challenges hindering progress in cancer research.
  • Identification of critical areas requiring further investigation and development.

Key Insights:

  • Consolidated expert opinions on the status of cancer research.
  • Discussion on the interplay between different cancer research specializations.

Outlook:

  • Opportunities for advancing cancer research through collaboration and innovation.
  • Future directions and potential breakthroughs in understanding and treating cancer.